NCT04764695Completed
Body Composition and Nutritional Status in Pediatric Patients With Hematological Malignancies
Evaluation of Body Composition and Nutritional Status in Pediatric Patients With Hematological Malignancies
Source: ClinicalTrials.gov · Last updated 6 Dec 2024
Brief summary (registry, in English)
Introduction: Annually 400,000 children are diagnosed with cancer in the world. Approximately 90% live in low/middle-income countries, with survival rates of 10-30%. In Mexico, children and adolescents' hospital admissions for cancer are mainly leukemias (46%), being acute lymphoblastic leukemia (ALL) the most common. Half of ALL patients have an altered nutritional status at the time of diagnosis. Nutritional assessment is performed using conventional anthropometric measures, which are not sensitive to changes in fat-free mass and fat mass (FFM and FFM). Our objective is to evaluate the body composition and nutritional status in pediatric patients with HM. This is a pre-test/post-test clinical trial. Children 2-14 y olds diagnosed with leukemia, myeloma and lymphoma in any stage of oncological treatment will participate. The nutritional status will be evaluated using questionnaires and body composition. Measurements will occur at the enrrollment of the study and 6 months after.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 38 (actual)
- First submitted
- 10 Feb 2021
- Start date
- Jan 2023
- Primary completion date
- Aug 2024
- Lead sponsor
- Universidad de Sonora
- Diseases
- Obesity, Childhood cancers
- NCT number
- NCT04764695
What you commit to
- Study type: Interventional
- Participants enrolled: 38
- From Jan 2023 to the primary completion date, Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Pathological conditions that can alter body composition (diabetes, hypothyroidism, among others)
Other
- Patients with sepsis that causes hemodynamic compromise and cannot be evaluated
- Severely ill patients unable to participate in baseline measurements
- Relapsed patients
- Patients with developmental problems of a genetic order as well as innate errors of metabolism
Who the study is looking for
- Patients in remission stage (4 - 6 weeks)
- Life expectancy\> 6 months and sufficient general conditions according to scales (Lansky ≥ 50 points for children \<16 years)
- Histopathological/molecular clinical confirmation of the HM diagnosis
- Signature of the consent by the relative or legal guardian of the patient and as well as the consent informed by the patient.
Age in the registry: 2 years to 14 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universidad de Sonora Coordinator of this site? Confirm its status | Hermosillo | Mexico | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.